Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Sollis Therapeutics Stock

sollistx.comHealthcareFounded: 2017Funding to Date: $49.89MM

Sollis Therapeutics is a clinical-stage pharmaceutical company developing novel interventional non-steroid, non-opioid analgesics.

Buy or sell Sollis Therapeutics stock Learn more about Sollis Therapeutics IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Sollis Therapeutics.

Register Today

Team

Management Team

Gregory Fiore MD

Co-Founder, Chief Executive Officer, President and Board Member

Bryan Jones JD

Chief Operating Officer & Co-Founder

Board Members

Greg Licholai MD

Richard Mott

Andrew ElBardissi MD

Deerfield Management

Kevin Wasserstein

Neurotechnology Innovations Translator

Gregory Fiore MD

Steven Hochberg

Other companies like Sollis Therapeutics in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Sector

Precision Neuroscience

Sector

Frequently Asked Questions